Ornopia, Shanlee .
HRN: 28-69-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/13/2026
03/20/2026
IV
410mg
Q6h
T/C Bacterial Skin Infection
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: